Free Trial

Dawson James Analyst Recommendations & Stock Picks

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Dawson James. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Dawson James.

MarketBeat Brokerage Ranking:
Average 12-Month ROI of Buy Recommendations: Subscribe to Unlock


MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionRatingPrice TargetDetailsActions
Tonix Pharmaceuticals stock logo
TNXP
Tonix Pharmaceuticals
$39.01
+3.5%
2/28/2024-Initiated CoverageBuy$9,600.00View details for Dawson James rating of Tonix Pharmaceuticals (NASDAQ:TNXP) on 2/28/2024
Dare Bioscience stock logo
DARE
Dare Bioscience
$2.42
+0.8%
1/30/2024J. KolbertDowngradeBuy -> NeutralView details for Dawson James rating of Dare Bioscience (NASDAQ:DARE) on 1/30/2024
Byrna Technologies stock logo
BYRN
Byrna Technologies
$21.32
-4.0%
9/27/2023-DowngradeBuy -> NeutralView details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 9/27/2023
Hillstream BioPharma stock logo
HILS
Hillstream BioPharma
$1.24
-0.4%
7/17/2023J. KolbertDowngradeBuy -> NeutralView details for Dawson James rating of Hillstream BioPharma (NASDAQ:HILS) on 7/17/2023
Byrna Technologies stock logo
BYRN
Byrna Technologies
$21.32
-4.0%
7/12/2023-Lower Price Target$9.50 -> $7.25View details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 7/12/2023
Kartoon Studios stock logo
TOON
Kartoon Studios
$0.65
-5.7%
7/11/2023-Lower Price Target$12.50 -> $10.00View details for Dawson James rating of Kartoon Studios (NASDAQ:TOON) on 7/11/2023
NRx Pharmaceuticals stock logo
NRXP
NRx Pharmaceuticals
$2.59
-3.7%
3/17/2023J. KolbertReiterated RatingBuyView details for Dawson James rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/17/2023
GeoVax Labs stock logo
GOVX
GeoVax Labs
$0.72
+0.6%
3/3/2023-Initiated CoverageBuy$60.00View details for Dawson James rating of GeoVax Labs (NASDAQ:GOVX) on 3/3/2023
Hillstream BioPharma stock logo
HILS
Hillstream BioPharma
$1.24
-0.4%
2/22/2023J. KolbertReiterated RatingBuyView details for Dawson James rating of Hillstream BioPharma (NASDAQ:HILS) on 2/22/2023
Smith Micro Software stock logo
SMSI
Smith Micro Software
$0.70
+2.1%
2/28/2023-Lower Price Target$66.40 -> $28.00View details for Dawson James rating of Smith Micro Software (NASDAQ:SMSI) on 2/28/2023
BioCardia stock logo
BCDA
BioCardia
$2.13
-0.5%
11/11/2022J. KolbertDowngradeBuy -> NeutralView details for Dawson James rating of BioCardia (NASDAQ:BCDA) on 11/11/2022
Byrna Technologies stock logo
BYRN
Byrna Technologies
$21.32
-4.0%
9/8/2022-Lower Price Target$12.00 -> $9.50View details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 9/8/2022
ProPhase Labs stock logo
PRPH
ProPhase Labs
$0.33
-9.3%
7/21/2022-DowngradeNeutral -> SellView details for Dawson James rating of ProPhase Labs (NASDAQ:PRPH) on 7/21/2022
Dyadic International stock logo
DYAI
Dyadic International
$1.01
-5.2%
7/18/2022J. KolbertDowngradeBuy -> NeutralView details for Dawson James rating of Dyadic International (NASDAQ:DYAI) on 7/18/2022
Kura Oncology stock logo
KURA
Kura Oncology
$6.02
-0.5%
5/16/2022J. KolbertDowngradeBuy -> NeutralView details for Dawson James rating of Kura Oncology (NASDAQ:KURA) on 5/16/2022
Byrna Technologies stock logo
BYRN
Byrna Technologies
$21.32
-4.0%
4/26/2022-Initiated CoverageBuy$12.00View details for Dawson James rating of Byrna Technologies (NASDAQ:BYRN) on 4/26/2022
Lineage Cell Therapeutics stock logo
LCTX
Lineage Cell Therapeutics
$0.99
-3.4%
3/11/2022Jason KolbertReiterated RatingBuy$6.00View details for Dawson James rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/11/2022
Smith Micro Software stock logo
SMSI
Smith Micro Software
$0.70
+2.1%
3/11/2022-Lower Price TargetBuy$91.20 -> $66.40View details for Dawson James rating of Smith Micro Software (NASDAQ:SMSI) on 3/11/2022
Know Labs stock logo
KNW
Know Labs
$2.68
-2.9%
2/8/2022-Initiated CoverageBuy$280.00View details for Dawson James rating of Know Labs (NYSEAMERICAN:KNW) on 2/8/2022
Vuzix stock logo
VUZI
Vuzix
$1.94
-3.5%
12/21/2021-Initiated CoverageBuy$15.00View details for Dawson James rating of Vuzix (NASDAQ:VUZI) on 12/21/2021
ProPhase Labs stock logo
PRPH
ProPhase Labs
$0.33
-9.3%
10/13/2021J. KolbertDowngradeBuy -> NeutralView details for Dawson James rating of ProPhase Labs (NASDAQ:PRPH) on 10/13/2021
Smith Micro Software stock logo
SMSI
Smith Micro Software
$0.70
+2.1%
8/5/2021-Initiated CoverageBuy$88.80View details for Dawson James rating of Smith Micro Software (NASDAQ:SMSI) on 8/5/2021
Anavex Life Sciences stock logo
AVXL
Anavex Life Sciences
$11.20
-0.9%
6/21/2021-Boost Price TargetBuy$19.00 -> $35.00View details for Dawson James rating of Anavex Life Sciences (NASDAQ:AVXL) on 6/21/2021
BioCardia stock logo
BCDA
BioCardia
$2.13
-0.5%
4/22/2021J. KolbertReiterated RatingBuy -> NeutralView details for Dawson James rating of BioCardia (NASDAQ:BCDA) on 4/22/2021
BioCardia stock logo
BCDA
BioCardia
$2.13
-0.5%
4/16/2021J. KolbertDowngradeBuy -> NeutralView details for Dawson James rating of BioCardia (NASDAQ:BCDA) on 4/16/2021
Citius Pharmaceuticals stock logo
CTXR
Citius Pharmaceuticals
$1.29
-5.8%
2/25/2021J. KolbertReiterated RatingBuy$150.00View details for Dawson James rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 2/25/2021
Fortress Biotech stock logo
FBIO
Fortress Biotech
$1.81
-2.2%
2/17/2021-Boost Price TargetBuy$240.00 -> $315.00View details for Dawson James rating of Fortress Biotech (NASDAQ:FBIO) on 2/17/2021
ProPhase Labs stock logo
PRPH
ProPhase Labs
$0.33
-9.3%
1/20/2021-Initiated CoverageBuy$25.00View details for Dawson James rating of ProPhase Labs (NASDAQ:PRPH) on 1/20/2021
Lineage Cell Therapeutics stock logo
LCTX
Lineage Cell Therapeutics
$0.99
-3.4%
10/12/2020-Reiterated RatingBuy$6.00View details for Dawson James rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 10/12/2020
Citius Pharmaceuticals stock logo
CTXR
Citius Pharmaceuticals
$1.29
-5.8%
9/17/2020J. KolbertReiterated RatingBuyView details for Dawson James rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 9/17/2020
Dare Bioscience stock logo
DARE
Dare Bioscience
$2.42
+0.8%
7/12/2020-Reiterated RatingBuy$36.00View details for Dawson James rating of Dare Bioscience (NASDAQ:DARE) on 7/12/2020
Anavex Life Sciences stock logo
AVXL
Anavex Life Sciences
$11.20
-0.9%
6/8/2020-Reiterated RatingBuy$16.00View details for Dawson James rating of Anavex Life Sciences (NASDAQ:AVXL) on 6/8/2020
Cytosorbents stock logo
CTSO
Cytosorbents
$0.87
+2.3%
3/9/2020-Reiterated RatingBuy$15.00 -> $17.00View details for Dawson James rating of Cytosorbents (NASDAQ:CTSO) on 3/9/2020
Dyadic International stock logo
DYAI
Dyadic International
$1.01
-5.2%
2/26/2020Jason KolbertReiterated RatingBuyView details for Dawson James rating of Dyadic International (NASDAQ:DYAI) on 2/26/2020
Mesoblast stock logo
MESO
Mesoblast
$15.17
-0.6%
12/19/2019Jason KolbertInitiated CoverageBuy$28.00View details for Dawson James rating of Mesoblast (NASDAQ:MESO) on 12/19/2019
Dyadic International stock logo
DYAI
Dyadic International
$1.01
-5.2%
10/16/2019-Initiated CoverageBuy$14.00View details for Dawson James rating of Dyadic International (NASDAQ:DYAI) on 10/16/2019
BioCardia stock logo
BCDA
BioCardia
$2.13
-0.5%
9/17/2019Jason KolbertInitiated CoverageBuy$360.00View details for Dawson James rating of BioCardia (NASDAQ:BCDA) on 9/17/2019
BioCardia stock logo
BCDA
BioCardia
$2.13
-0.5%
9/17/2019J. KolbertReiterated RatingBuyView details for Dawson James rating of BioCardia (NASDAQ:BCDA) on 9/17/2019
Citius Pharmaceuticals stock logo
CTXR
Citius Pharmaceuticals
$1.29
-5.8%
9/6/2019Jason KolbertInitiated CoverageBuy$175.00View details for Dawson James rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 9/6/2019
Fortress Biotech stock logo
FBIO
Fortress Biotech
$1.81
-2.2%
8/26/2019-Initiated CoverageBuy$285.00View details for Dawson James rating of Fortress Biotech (NASDAQ:FBIO) on 8/26/2019
One stock to replace Nvidia (Ad)

Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.

Click to get the full details on Eric Fry's "Nvidia alternative" right here.
ADMA Biologics stock logo
ADMA
ADMA Biologics
$19.33
+3.4%
8/12/2019J. KolbertDowngradeBuy -> Neutral$4.00View details for Dawson James rating of ADMA Biologics (NASDAQ:ADMA) on 8/12/2019
Anavex Life Sciences stock logo
AVXL
Anavex Life Sciences
$11.20
-0.9%
7/24/2019J. KolbertInitiated CoverageBuy$16.00View details for Dawson James rating of Anavex Life Sciences (NASDAQ:AVXL) on 7/24/2019
Kura Oncology stock logo
KURA
Kura Oncology
$6.02
-0.5%
7/11/2019J. KolbertReiterated RatingBuyView details for Dawson James rating of Kura Oncology (NASDAQ:KURA) on 7/11/2019
inTEST stock logo
INTT
inTEST
$7.07
+1.1%
12/28/2018B. SineReiterated RatingBuyView details for Dawson James rating of inTEST (NYSE:INTT) on 12/28/2018
WidePoint stock logo
WYY
WidePoint
$3.02
+0.3%
12/3/2018B. SineReiterated RatingBuyView details for Dawson James rating of WidePoint (NYSEAMERICAN:WYY) on 12/3/2018
Wireless Telecom Group stock logo
WTT
Wireless Telecom Group
$2.13
12/3/2018B. SineReiterated RatingBuyView details for Dawson James rating of Wireless Telecom Group (NYSEAMERICAN:WTT) on 12/3/2018
Cineverse stock logo
CNVS
Cineverse
$5.16
+2.4%
10/22/2018B. SineInitiated CoverageBuyView details for Dawson James rating of Cineverse (NASDAQ:CNVS) on 10/22/2018
Fennec Pharmaceuticals stock logo
FRX
Fennec Pharmaceuticals
C$11.01
-3.4%
10/10/2018C. WertherReiterated RatingBuyView details for Dawson James rating of Fennec Pharmaceuticals (TSE:FRX) on 10/10/2018
Adherex Technologies stock logo
FENC
Adherex Technologies
$7.84
-4.2%
10/11/2018C. WertherInitiated CoverageBuyView details for Dawson James rating of Adherex Technologies (NASDAQ:FENC) on 10/11/2018
Luna Innovations stock logo
LUNA
Luna Innovations
$1.00
10/2/2018B. SineInitiated CoverageBuyView details for Dawson James rating of Luna Innovations (NASDAQ:LUNA) on 10/2/2018
Veru stock logo
VERU
Veru
$0.49
+1.8%
6/25/2018R. WassermanReiterated RatingBuyView details for Dawson James rating of Veru (NASDAQ:VERU) on 6/25/2018
LiveOne stock logo
LVO
LiveOne
$0.65
-0.9%
6/4/2018B. SineReiterated RatingBuyView details for Dawson James rating of LiveOne (NASDAQ:LVO) on 6/4/2018
Altimmune stock logo
ALT
Altimmune
$3.61
-2.2%
5/29/2018R. WassermanReiterated RatingBuyView details for Dawson James rating of Altimmune (NASDAQ:ALT) on 5/29/2018
CEL-SCI stock logo
CVM
CEL-SCI
$9.45
+15.5%
10/16/2017R. WassermanReiterated RatingNeutralView details for Dawson James rating of CEL-SCI (NYSE:CVM) on 10/16/2017
Tonix Pharmaceuticals stock logo
TNXP
Tonix Pharmaceuticals
$39.01
+3.5%
8/23/2017R. WassermanReiterated RatingBuy$57,600,000.00View details for Dawson James rating of Tonix Pharmaceuticals (NASDAQ:TNXP) on 8/23/2017
Kura Oncology stock logo
KURA
Kura Oncology
$6.02
-0.5%
8/8/2017R. WassermanReiterated RatingBuyView details for Dawson James rating of Kura Oncology (NASDAQ:KURA) on 8/8/2017
ESSA Pharma stock logo
EPIX
ESSA Pharma
$1.88
8/3/2017R. WassermanReiterated RatingBuyView details for Dawson James rating of ESSA Pharma (NASDAQ:EPIX) on 8/3/2017
CEL-SCI stock logo
CVM
CEL-SCI
$9.45
+15.5%
3/11/2016R. WassermanReiterated RatingBuyView details for Dawson James rating of CEL-SCI (NYSE:CVM) on 3/11/2016
Soleno Therapeutics stock logo
SLNO
Soleno Therapeutics
$86.00
-0.5%
5/6/2015-Initiated CoverageBuy$952.50View details for Dawson James rating of Soleno Therapeutics (NASDAQ:SLNO) on 5/6/2015
CEL-SCI stock logo
CVM
CEL-SCI
$9.45
+15.5%
3/2/2015-Initiated CoverageBuy$90.00View details for Dawson James rating of CEL-SCI (NYSE:CVM) on 3/2/2015
AxoGen stock logo
AXGN
AxoGen
$12.67
-3.2%
5/14/2014-Initiated CoverageBuy$5.00View details for Dawson James rating of AxoGen (NASDAQ:AXGN) on 5/14/2014
NeoGenomics stock logo
NEO
NeoGenomics
$5.16
+6.6%
5/14/2014-Initiated CoverageBuy$6.00View details for Dawson James rating of NeoGenomics (NASDAQ:NEO) on 5/14/2014
Agenus stock logo
AGEN
Agenus
$5.36
-2.9%
3/12/2013-Reiterated RatingBuyView details for Dawson James rating of Agenus (NASDAQ:AGEN) on 3/12/2013
Pediatrix Medical Group stock logo
MD
Pediatrix Medical Group
$11.98
-2.2%
3/12/2013-DowngradeBuy -> Neutral$80.00View details for Dawson James rating of Pediatrix Medical Group (NYSE:MD) on 3/12/2013
Arrowhead Pharmaceuticals stock logo
ARWR
Arrowhead Pharmaceuticals
$15.93
+0.8%
2/26/2013-Initiated CoverageBuy$4.00View details for Dawson James rating of Arrowhead Pharmaceuticals (NASDAQ:ARWR) on 2/26/2013
Atossa Genetics stock logo
ATOS
Atossa Genetics
$0.82
-1.3%
12/20/2012-Initiated CoverageOutperform$120.00View details for Dawson James rating of Atossa Genetics (NASDAQ:ATOS) on 12/20/2012
Bristol Myers Squibb stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
12/12/2012-Reiterated RatingMarket Outperform$51.00View details for Dawson James rating of Bristol Myers Squibb (NYSE:BMY) on 12/12/2012
Amgen stock logo
AMGN
Amgen
$296.88
+0.6%
12/7/2012-Initiated CoverageOutperform$91.00View details for Dawson James rating of Amgen (NASDAQ:AMGN) on 12/7/2012
Geo Group stock logo
GEO
Geo Group
$25.02
-3.5%
12/4/2012-DowngradeMarket PerformView details for Dawson James rating of Geo Group (NYSE:GEO) on 12/4/2012
Sarepta Therapeutics stock logo
SRPT
Sarepta Therapeutics
$15.91
-3.1%
11/27/2012-Initiated CoverageOutperformView details for Dawson James rating of Sarepta Therapeutics (NASDAQ:SRPT) on 11/27/2012
Rockwell Medical stock logo
RMTI
Rockwell Medical
$0.96
+2.8%
11/27/2012-Initiated CoverageOutperform$132.00View details for Dawson James rating of Rockwell Medical (NASDAQ:RMTI) on 11/27/2012
Agenus stock logo
AGEN
Agenus
$5.36
-2.9%
11/27/2012-Initiated CoverageOutperformView details for Dawson James rating of Agenus (NASDAQ:AGEN) on 11/27/2012
SELLAS Life Sciences Group stock logo
SLS
SELLAS Life Sciences Group
$1.66
+4.4%
11/27/2012-Initiated CoverageOutperform$150.00View details for Dawson James rating of SELLAS Life Sciences Group (NASDAQ:SLS) on 11/27/2012
Cytokinetics stock logo
CYTK
Cytokinetics
$36.69
-2.5%
11/27/2012-DowngradeOutperformView details for Dawson James rating of Cytokinetics (NASDAQ:CYTK) on 11/27/2012
Galectin Therapeutics stock logo
GALT
Galectin Therapeutics
$3.65
+0.3%
7/6/2012-Lower Price TargetBuy$3.00View details for Dawson James rating of Galectin Therapeutics (NASDAQ:GALT) on 7/6/2012
Tonix Pharmaceuticals stock logo
TNXP
Tonix Pharmaceuticals
$39.01
+3.5%
4/26/2012-Initiated CoverageBuy$25,600,000.00View details for Dawson James rating of Tonix Pharmaceuticals (NASDAQ:TNXP) on 4/26/2012
Netflix stock logo
NFLX
Netflix
$1,158.60
-0.1%
10/28/2011-Lower Price TargetSell$16.50 -> $7.14View details for Dawson James rating of Netflix (NASDAQ:NFLX) on 10/28/2011
EOM Pharmaceutical stock logo
IMUC
EOM Pharmaceutical
$0.10
3/22/2011-Initiated CoverageBuy$5.00View details for Dawson James rating of EOM Pharmaceutical (OTCMKTS:IMUC) on 3/22/2011

MarketBeat Community Rating for Dawson James

Community Ranking:  2.6 out of 5 (
2.6 of 5 stars)
Outperform Votes:  49,944 (Vote Outperform)
Underperform Votes:  47,205 (Vote Underperform)
Total Votes:  97,149
MarketBeat's community ratings are surveys of what our community members think about Dawson James and other research firms. Vote "Outperform" if you believe Dawson James's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Dawson James's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.